🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 4 of 757 · Phase 3 first, then by program name

  1. 5% cysteamine cream

    China SXT Pharmaceuticals

    Melasma

    phase 3 other completed

    1 trial

  2. 5% minoxidil foam

    Sunshine Biopharma

    Androgenetic Alopecia

    phase 3 small molecule active

    1 trial

  3. 5-FU medac 50 mg/ml, Injektionslösung, Tecentriq 1 200 mg concentrate for solution for infusion, Docetaxel Accord 20 mg/1 ml concentrate for solution for infusion, Leucovorin 10 mg/ml Lösung zur Injektion/ Infusion, Oxaliplatin medac 5 mg/ml concentrate for solution for infusion

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    locally advanced resectable adenocarcinoma of the oesophagogastric junction or the stomach

    phase 3 small molecule active

    1 trial

  4. 5-Fu/epirubicin/CTX following Docetaxel

    China SXT Pharmaceuticals

    Breast Cancer

    phase 3 small molecule active

    1 trial

  5. 5mg Serlopitant Tablets

    VYNE Therapeutics

    Pruritus

    phase 3 small molecule completed

    2 trials

  6. 6-Thio-2'-Deoxyguanosine

    MAIA Biotechnology

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule active

    2 trials

  7. 6-month course of antiandrogen drugs

    First Tracks Biotherapeutics

    Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

    phase 3 small molecule active

    1 trial

  8. 60 mg ulixacaltamide

    PRECISION BIOSCIENCES INC

    Essential Tremor

    phase 3 small molecule active

    1 trial

  9. 600 mg Ibuprofen

    United Therapeutics Europe Ltd

    Tibial Fractures

    phase 3 small molecule active

    1 trial

  10. 601 1.25mg

    Sunshine Biopharma

    Branch Retinal Vein Occlusion

    phase 3 small molecule completed

    2 trials

  11. 608

    Sunshine Biopharma

    Axial Spondyloarthritis, Non-Radiographic

    phase 3 small molecule active

    1 trial

  12. 608 Q2W

    Sunshine Biopharma

    Plaque Psoriasis Patients

    phase 3 small molecule active

    1 trial

  13. 608 Q2W

    Sunshine Biopharma

    Psoriasis

    phase 3 small molecule completed

    1 trial

  14. 608 dose

    Sunshine Biopharma

    Ankylosing Spondylitis

    phase 3 small molecule active

    1 trial

  15. 610

    Sunshine Biopharma

    Asthma

    phase 3 small molecule active

    2 trials

  16. 611

    Sunshine Biopharma

    Pulmonary Disease, Chronic Obstructive (COPD)

    phase 3 small molecule active

    1 trial

  17. 611

    Sunshine Biopharma

    Sinusitis

    phase 3 small molecule active

    2 trials

  18. 611

    Sunshine Biopharma

    Dermatitis, Atopic

    phase 3 small molecule active

    3 trials

  19. 64Cu(II)Cl2 solution for injection

    A.C.O.M. - Advanced Center Oncology

    Cancer on the prostatic bed

    phase 3 small molecule active

    1 trial

  20. 64Cu(II)Cl2 solution for injection, Fluorocolina (18F) Curium Italy 225 MBq/mL soluzione iniettabile

    A.C.O.M. - Advanced Center Oncology

    Prostate cancer at risk of developing metastatic lesions

    phase 3 small molecule active

    1 trial

  21. 64Cu-PSMA I&T

    Curium Romania S.R.L.

    Prostate cancer

    phase 3 small molecule active

    1 trial

  22. 64Cu-PSMA I&T

    Curium Romania S.R.L.

    Prostate cancer

    phase 3 small molecule active

    1 trial

  23. 68Ga-PSMA-11

    Telix Innovations

    PCA

    phase 3 small molecule active

    1 trial

  24. 68Ga-PSMA-11

    China SXT Pharmaceuticals

    Biochemical Recurrence of Malignant Neoplasm of Prostate

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources